On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide)
COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
By managing blood sugar levels and promoting weight loss, semaglutide may indirectly reduce the risk of gout flare-ups
[7] Published experience and post-marketing reports suggest that adverse reactions to topical GHK-Cu are uncommon and, when they occur, tend to be mild and localized
GLP1 Medications Show New Benefits New research presented at ENDO 2025, the Endocrine Societys leading international conference on hormone science, reveals that GLP1 medications like semaglutide, dulaglutide, and tirzepatide may raise testosterone levels in men with obesity and type 2 diabetes
How Much Can I Win in a Saxenda Lawsuit